Promoters of Kauvery Hospitals are in advanced negotiations to repurchase roughly 5% stake from investor Lightrock a move that could consolidate promoter control as the hospital chain eyes a public listing reportedly valuing the firm at ₹5,000 crore.
Glimpse:
The proposed buy-back would come nearly two years after the chain’s last funding round in 2023 when a minority stake was sold at a valuation of ₹3,400 crore. With plans to add up to 1,000 beds by FY27 and a capital expenditure of ₹580 crore, the repurchase appears aligned with long-term growth and IPO readiness.
According to sources familiar with the matter, promoters of Kauvery Hospitals officially known as Sri Kauvery Medical Care (India) Ltd. are in “advanced talks” to acquire approximately 5% stake from Lightrock. This deal is being negotiated as part of a broader strategy to strengthen promoter-driven control ahead of a planned initial public offering (IPO). The hospital chain’s estimated valuation in these talks is about ₹5,000 crore.
Back in 2023, the group raised about $70 million from a private equity fund managed by IIFL Asset Management Limited (IIFL AMC) valuing the company around ₹3,400 crore. The current move to repurchase stakeholder share comes as the chain readies itself for expansion and possible public listing within the next 2–3 years.
At present, promoters reportedly hold around 47% of the company. Other major shareholders include IIFL AMC, Lightrock and investor family offices. Lightrock which had earlier invested roughly ₹140 crore held approximately 11% before the proposed sale. Under the new plan, promoters may match any competing bids, showing intent to take back the stake rather than let it go to an outside buyer.
Kauvery Hospitals runs a network of hospitals across South India. The group plans to expand its bed capacity significantly aiming for roughly 1,000 additional beds between FY25 and FY27 under a capex plan of ₹580 crore. Growth ambitions, combined with stake consolidation, suggest an aggressive push for scale and market positioning ahead of the IPO
“As we gear up for the next growth phase, regaining stakeholder control ensures we stay focused on our long-term vision expansion, quality care and sustainable scale.”
By
HB Team

